Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Archetypal Analysis Demonstrates Visual Field Patterns of Loss and Evolution in Non-Arteritic Anterior Ischemic Optic Neuropathy
Author Affiliations & Notes
  • David Szanto
    Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Brian Woods
    Irish Clinical Academic Programme, Galway University Hospitals, Galway, Galway, Ireland
  • Jui-Kai Wang
    Department of Ophthalmology and Visual Sciences, University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
    Iowa City VA Center for the Prevention and Treatment of Visual Loss, Iowa City, Iowa, United States
  • Tobias Elze
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Mona K Garvin
    Iowa City VA Center for the Prevention and Treatment of Visual Loss, Iowa City, Iowa, United States
    Department of Electrical and Computer Engineering, University of Iowa Center for the Prevention and Treatment of Visual Loss, Iowa City, Iowa, United States
  • Louis R Pasquale
    Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Randy H Kardon
    Iowa City VA Center for the Prevention and Treatment of Visual Loss, Iowa City, Iowa, United States
    Department of Ophthalmology and Visual Sciences, University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
  • Joseph Branco
    Department of Ophthalmology, New York Medical College, Valhalla, New York, United States
  • Asala Erekat
    Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Mark J Kupersmith
    Departments of Neurology, Ophthalmology and Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Footnotes
    Commercial Relationships   David Szanto None; Brian Woods None; Jui-Kai Wang None; Tobias Elze Genentech Inc., Code F (Financial Support); Mona Garvin University of Iowa, Code P (Patent); Louis Pasquale Twenty Twenty Inc, Skye Biosciences, Code C (Consultant/Contractor); Randy Kardon None; Joseph Branco None; Asala Erekat None; Mark Kupersmith None
  • Footnotes
    Support  New York Eye and Ear Infirmary Foundation, Shulman Family NAION Fund
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1007. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      David Szanto, Brian Woods, Jui-Kai Wang, Tobias Elze, Mona K Garvin, Louis R Pasquale, Randy H Kardon, Joseph Branco, Asala Erekat, Mark J Kupersmith; Archetypal Analysis Demonstrates Visual Field Patterns of Loss and Evolution in Non-Arteritic Anterior Ischemic Optic Neuropathy. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1007.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In non-arteritic anterior ischemic optic neuropathy (NAION), global measures but not quantification of the patterns of visual field (VF) loss have been reported. Further, no prospective trials of optic nerve dysfunction have been conducted using stimulus V. Given the frequency of severe VF deficits in NAION, we incorporated stimulus V VFs, which show important patterns of VF loss with better quality metrics, without sacrificing reliability/sensitivity. We applied archetypal analysis (AA), a machine learning algorithm, to the QRK207 study, the largest prospective study of NAION, to uncover distinct patterns of loss (archetypes, ATs) over time.

Methods : We performed AA on 3157 24-2 VFs (combining stimuli III and V) collected from 728 participants. We used the resulting ATs to track disease progression by examining AT relative weights (RW, total weight = 100%) of 190 untreated eyes at presentation, and at months 2 and 6. We compared 146 pairs of stimulus III VFs at presentation and 2 months, and 107 pairs of stimulus V VFs at presentation and 6 months with a Wilcoxon Rank-Sum Test.

Results : AA revealed 10 distinct ATs, with patterns typically seen in the clinic. The diffuse severe loss AT1 (RW 16%), followed by inferior altitudinal loss AT2 (RW 15%), and diffuse mild loss AT3 (RW 13%) were the most common ATs. From presentation to month 2 (stimulus III), the RW of AT1 increased from 15% to 21% (p = 0.02), the RW of AT2 decreased from 21% to 13% (p < 0.001), and the AT3 RW changed minimally (9%, p = 0.75). Between presentation and month 6 (stimulus V), the change in AT RWs were similar to stimulus III; the RW of AT1 increased from 11% to 16% (p = 0.049), AT2 decreased from 16% to 10% (p = 0.009), and AT3 minimally changed (14%, p = 0.56).

Conclusions : AA identifies recognizable patterns and quantifiable RWs within stimuli III and V VFs in NAION, enabling accurate monitoring of disease changes.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Figure 1. Archetypes for combined stimuli III and V VFs. The different shades of red within every archetype represent total deviation values. The color scale spans from -30 dB to 0 dB. We show each archetype with its average total deviation value and relative weight, displayed as a percentage within the dataset for both stimulus III and V. The archetypes are numbered and arranged based on their relative weight.

Figure 1. Archetypes for combined stimuli III and V VFs. The different shades of red within every archetype represent total deviation values. The color scale spans from -30 dB to 0 dB. We show each archetype with its average total deviation value and relative weight, displayed as a percentage within the dataset for both stimulus III and V. The archetypes are numbered and arranged based on their relative weight.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×